glp 1 hba1c reduction Most Patients with Type 2 Diabetes Maintain Improvements a Year After Stopping GLP-1 Medications GLP-1 agonists in glycemic and

Tirzepatide works through both GLP-1 and GIP pathways

GLP-1 stands for glucagon-like peptide-1, a hormone that helps regulate appetite and blood sugar

Understanding how these treatments interact with hypertension helps patients and clinicians optimise both diabetes control and cardiovascular risk reduction

GLP-1R as a potential link between diabetes and Alzheimers disease: Mechanistic insights and therapeutic opportunities

Specifically, STEP 5 was a 2-year trial that included participants with overweight or obesity

These findings suggest that it is possible to increase GLP-1 secretion and manage T2DM and its complications by restoring and improving the gut microbiota [158]